Federal Contractor Profile
Resilience Government Services, INC.
$291.8M obligated·18 awards·2 agencies·5 NAICS
Federal Contracts
Showing contracts 51–81 of 81 total. Sorted by action date, most recent first. Excludes $0 modifications.
| Date | Agency | PIID | NAICS | Description | Amount |
|---|---|---|---|---|---|
| Nov 20, 2019 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0010 | 325412 | MEDICAL COUNTERMEASURES ADVANCED DEVELOPMENT AND MANUFACTURING (MCM ADM) CAPABILITY | $2.4M |
| Sep 27, 2019 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0010 | 325412 | MEDICAL COUNTERMEASURES ADVANCED DEVELOPMENT AND MANUFACTURING (MCM ADM) CAPABILITY | $802K |
| Sep 10, 2019 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0010 | 325412 | MEDICAL COUNTERMEASURES ADVANCED DEVELOPMENT AND MANUFACTURING (MCM ADM) CAPABILITY | $7.8M |
| Aug 30, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93019C00057 | 541714 | TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018 | $3.4M |
| May 23, 2019 | Department of DefenseW6QK ACC-APG NATICK | W911QY19C0049 | 541714 | PMR AND PMC | $3K |
| Apr 10, 2019 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0010 | 325412 | MEDICAL COUNTERMEASURES ADVANCED DEVELOPMENT AND MANUFACTURING (MCM ADM) CAPABILITY | $900K |
| Apr 1, 2019 | Department of DefenseW6QK ACC-APG NATICK | W911QY19C0049 | 541714 | PMR AND PMC | $694K |
| Mar 28, 2019 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0010 | 325412 | MEDICAL COUNTERMEASURES ADVANCED DEVELOPMENT AND MANUFACTURING (MCM ADM) CAPABILITY | $7.0M |
| Jan 22, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | HHSN27200002 | 541711 | IGF::OT::IGF PURPOSE: TO ISSUE TASK ORDER HHSN27200002 (B-001) ENTITLED "STABILITY TESTING OF NTM-1632 AND NTM-1633. | $251K |
| Dec 17, 2018 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0010 | 325412 | MEDICAL COUNTERMEASURES ADVANCED DEVELOPMENT AND MANUFACTURING (MCM ADM) CAPABILITY | $4.8M |
| Dec 3, 2018 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0010 | 325412 | MEDICAL COUNTERMEASURES ADVANCED DEVELOPMENT AND MANUFACTURING (MCM ADM) CAPABILITY | $3.5M |
| Sep 4, 2018 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0010 | 325412 | MEDICAL COUNTERMEASURES ADVANCED DEVELOPMENT AND MANUFACTURING (MCM ADM) CAPABILITY | $2.7M |
| Aug 10, 2018 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0010 | 325412 | MEDICAL COUNTERMEASURES ADVANCED DEVELOPMENT AND MANUFACTURING (MCM ADM) CAPABILITY | $2.9M |
| Jul 19, 2018 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0010 | 325412 | MEDICAL COUNTERMEASURES ADVANCED DEVELOPMENT AND MANUFACTURING (MCM ADM) CAPABILITY | $1.4M |
| Jun 12, 2018 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0010 | 325412 | MEDICAL COUNTERMEASURES ADVANCED DEVELOPMENT AND MANUFACTURING (MCM ADM) CAPABILITY | $2.0M |
| Jun 1, 2018 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0010 | 325412 | MEDICAL COUNTERMEASURES ADVANCED DEVELOPMENT AND MANUFACTURING (MCM ADM) CAPABILITY | $5.9M |
| May 22, 2018 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0010 | 325412 | MEDICAL COUNTERMEASURES ADVANCED DEVELOPMENT AND MANUFACTURING (MCM ADM) CAPABILITY | $4.8M |
| Mar 22, 2018 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0010 | 325412 | MEDICAL COUNTERMEASURES ADVANCED DEVELOPMENT AND MANUFACTURING (MCM ADM) CAPABILITY | $4.7M |
| Jan 25, 2018 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0010 | 325412 | MEDICAL COUNTERMEASURES ADVANCED DEVELOPMENT AND MANUFACTURING (MCM ADM) CAPABILITY | $2.4M |
| Dec 6, 2017 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0010 | 325412 | MEDICAL COUNTERMEASURES ADVANCED DEVELOPMENT AND MANUFACTURING (MCM ADM) CAPABILITY | $2.5M |
| Sep 5, 2017 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | HHSN272201600009C | 541711 | IGF::OT::IGF BROAD SPECTRUM MONOCLONAL ANTIBODY-BASED THERAPEUTIC FOR BOTULISM PURPOSE: TO OBLIGATE FUNDS TRANSFERRED FROM HHSN272201100031C LINE 1: $928,803.41 LINE 3: $2,920,953.48 LINE 4: $1,647,835.46 | $284K |
| Aug 7, 2017 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | HHSN27200002 | 541711 | IGF::OT::IGF PURPOSE: TO ISSUE TASK ORDER HHSN27200002 (B-001) ENTITLED "STABILITY TESTING OF NTM-1632 AND NTM-1633. | $565K |
| Aug 3, 2017 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0010 | 325412 | MEDICAL COUNTERMEASURES ADVANCED DEVELOPMENT AND MANUFACTURING (MCM ADM) CAPABILITY | $2.0M |
| Jul 6, 2017 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO10033004T | 325414 | CDER PILOT: SUCCINYLCHOLINE CHLORIDE INJECTION SOLUTION ASEPTICALLY FILLED INTO 10 ML GLASS VIALS | $1.0M |
| Jun 29, 2017 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0010 | 325412 | MEDICAL COUNTERMEASURES ADVANCED DEVELOPMENT AND MANUFACTURING (MCM ADM) CAPABILITY | $336K |
| Mar 29, 2017 | Department of DefenseW6QK ACC-APG NATICK | W911QY13C0010 | 325412 | MEDICAL COUNTERMEASURES ADVANCED DEVELOPMENT AND MANUFACTURING (MCM ADM) CAPABILITY | $2.8M |
| Sep 2, 2016 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | HHSN27200001 | 541711 | IGF::OT::IGF PRECLINICAL SERVICES FOR BIOPHARMACEUTICAL PRODUCT DEVELOPMENT - TASK ORDER AREA F | $14K |
| Jul 26, 2016 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | HHSN272201600009C | 541711 | IGF::OT::IGF BROAD SPECTRUM MONOCLONAL ANTIBODY-BASED THERAPEUTIC FOR BOTULISM PURPOSE: TO OBLIGATE FUNDS TRANSFERRED FROM HHSN272201100031C LINE 1: $928,803.41 LINE 3: $2,920,953.48 LINE 4: $1,647,835.46 | $980K |
| Jul 15, 2016 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | HHSN272201600009C | 541711 | IGF::OT::IGF BROAD SPECTRUM MONOCLONAL ANTIBODY-BASED THERAPEUTIC FOR BOTULISM PURPOSE: TO OBLIGATE FUNDS TRANSFERRED FROM HHSN272201100031C LINE 1: $928,803.41 LINE 3: $2,920,953.48 LINE 4: $1,647,835.46 | $1.1M |
| May 10, 2016 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO10033002T | 325414 | IGF::OT::IGF | $219K |
| Mar 22, 2016 | Department of Health and Human ServicesNIH, NIAID DEA OA OFC ACQUISITIONS | HHSN272201600009C | 541711 | IGF::OT::IGF BROAD SPECTRUM MONOCLONAL ANTIBODY-BASED THERAPEUTIC FOR BOTULISM PURPOSE: TO OBLIGATE FUNDS TRANSFERRED FROM HHSN272201100031C LINE 1: $928,803.41 LINE 3: $2,920,953.48 LINE 4: $1,647,835.46 | $5.5M |
Get Alerted Before Resilience Government Services, INC.'s Next Recompete
Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.
Start Free